<DOC>
	<DOCNO>NCT01327326</DOCNO>
	<brief_summary>The aim proposal characterize pain inhibition healthy control Temporomandibular Disorder ( TMD ) patient two model endogenous pain modulation ( off-set analgesia ; condition pain modulation ) , investigate function endogenous opioid system responses use pharmacological blockade opioid receptor .</brief_summary>
	<brief_title>Role Endogenous Opioid System Underlying Modulation Experimental Pain</brief_title>
	<detailed_description>Dysfunction endogenous pain inhibitory system propose factor development maintenance clinical pain disorder particularly Temporomandibular Disorder ( TMD ) . Dysfunction observe model know diffuse noxious inhibitory control ( DNIC ) , model engage inhibitory system ( offset analgesia ) fully evaluate chronic pain patient . DNIC evaluate individual 's capacity engage endogenous pain inhibition . The paradigm spatial inhibition model base principle `` pain-inhibits-pain '' pain local area inhibit second pain anywhere else body . DNIC traditionally study observe reduction pain produce focal pain stimulus ( contact heat ) result second painful stimulus . Research lab others suggest pain inhibition reduce number chronic pain condition . The investigator preliminary data suggests pain inhibition DNIC modulate part endogenous opioids ; however , result DNIC study mix . In addition , possible reduction ability engage endogenous inhibitory system chronic pain patient due weaken endogenous opioid system . While pharmacological study conduct healthy cohort , one study examine opioid involvement chronic pain patient . Offset analgesia think reflect form temporal pain inhibition usually define three stimulus temperature phase : baseline phase follow manipulation phase temperature briefly increase return baseline temperature `` offset '' phase . A reduction pain rating observe approximately 15 temperature drop ( third phase ) , ~50 % low rating time point `` constant '' trial continue 48Â°C 40 . No study examine offset analgesia chronic pain cohort sensitivity opioid blockade .</detailed_description>
	<mesh_term>Temporomandibular Joint Disorders</mesh_term>
	<mesh_term>Temporomandibular Joint Dysfunction Syndrome</mesh_term>
	<mesh_term>Facial Pain</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>age 1850 year old Controls : painfree base Research Diagnostic Criteria ( RDC ) exam TMD : chronic musculoskeletal pain ( face ) base Research Diagnostic Criteria ( RDC ) exam Inability adequately communicate understand inform consent form ; Inability reliably rate pain intensity ; Uncontrolled hypertension ( receive treatment hypertension BP great 140/95 ) ; Serious systemic ( e.g . Diabetes , thyroid problem , etc . ) ; Serious cardiovascular/pulmonary disease ; Neurological problem significant change somatosensory pain perception intend stimulation site ( hand , foot ) ; Serious psychiatric problem require treatment ( schizophrenia , bipolar disorder ) ; Other chronic pain condition ( e.g. , low back pain , fibromyalgia ) ; Any ongoing acute pain problem ( arthritis , injuryrelated pain ) ; , Irregular menstrual cycle ( &gt; 40 day ) menstrual cycle disorder ( e.g . PMS , dysmenorrhea ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Pain modulation</keyword>
	<keyword>Experimental pain</keyword>
</DOC>